Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Kymera Therapeutics Inc shares valued at $2,903,336 were sold by Booth Bruce on Mar 15 ’24. At $40.46 per share, Booth Bruce sold 71,764 shares. The insider’s holdings dropped to 806,697 shares worth approximately $28.33 million following the completion of this transaction.
Also, Booth Bruce sold 55,779 shares, netting a total of over 2,229,927 in proceeds. Following the sale of shares at $39.98 each, the insider now holds 819,151 shares.
Before that, Booth Bruce had sold 139,255 shares from its account. In a trade valued at $5,880,415, the Director traded Kymera Therapeutics Inc shares for $42.23 each. Upon closing the transaction, the insider’s holdings decreased to 139,255 shares, worth approximately $29.11 million.
As published in their initiating research note from Wolfe Research on February 15, 2024, Kymera Therapeutics Inc [KYMR] has been a Peer perform. Analysts at JP Morgan upgraded the stock from ‘”a Neutral”‘ to ‘”an Overweight”‘ outlook in a report released in early January. As of January 03, 2024, BofA Securities has decreased its “Buy” rating to a “Neutral” for KYMR. Earlier on December 19, 2023, Wells Fargo downgraded its rating. Their new recommendation was “an Equal weight” for KYMR stock which previously was a “an Overweight”.
Analyzing KYMR Stock Performance
During the last five days, there has been a drop of approximately -5.62%. Over the course of the year, Kymera Therapeutics Inc shares have jumped approximately 37.94%. Shares of the company reached a 52-week high of $45.31 on 02/27/24 and a 52-week low of $22.35 on 01/04/24. A 50-day SMA is recorded $39.00, while a 200-day SMA reached $25.29. Nevertheless, trading volume fell to 0.62 million shares from 0.49 million shares the previous day.
Support And Resistance Levels for Kymera Therapeutics Inc (KYMR)
According to the 24-hour chart, there is a support level at 34.00, which, if violated, would cause prices to drop to 32.89. In the upper region, resistance lies at 35.90. The next price resistance is at 36.69. RSI (Relative Strength Index) is 41.34 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.88, which suggests the price will decrease in the coming days. Percent R is at 73.58%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
